An oral medication for a red blood cell dysfunction is approved as a consequence of phase 3 clinical trial findings
Editor The outcomes of the randomised placebo-controlled ACTIVATE trial were released in the New England Journal of Medicine and…
The outcomes of the randomised placebo-controlled ACTIVATE trial were released in the New England Journal of Medicine and…
